Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder

Table 4

The distribution of Toxoplasma gondii and Toxocara antibodies in patients with schizophrenia based on clinical course of treatment.

	Clinical course	𝑁 (%)	𝑃 value	OR	CI95
Toxoplasma gondii	First episode	13/30 (43.33%)	0.1	2.08	0.84–5.12
	Recurrent episodes	18/67 (26.86%)
Toxocara	First episode	8/30 (26.66%)	0.06	0.22	0.06–0.75
	Recurrent episodes	5/30 (16.66%)